All treatments
Treatment
PEX010 Psilocybin Capsules ( 25mg psilocybin) clinical trials
2 indexed studies · 1 currently recruiting
- RecruitingPhase I and Phase II (Integrated)- Other
Can a one-off administration of psilocybin reduce alcohol intake in patients with alcohol use disorder? A randomized, double-blinded, placebo-controlled clinical trial.
This clinical trial investigates whether a single dose of psilocybin, a compound found in magic mushrooms, can help adults cut down on heavy drinking. Researchers are comparing psilocybin capsules against a dummy treatment (placebo) to see if it reduces alcohol cravings and drinking days over a four-week period.
For: Alcohol Use DisorderDenmark - AuthorisedTherapeutic exploratory (Phase II)
The Acute and Long-term Impact of Support in Psilocybin Therapy for Depression: The Psilocybin Setting Trial (PSISET)
This UK clinical trial investigates psilocybin, a compound found in magic mushrooms, for treating depression. Researchers want to discover how different levels of psychological therapy affect how well the medicine works. They will compare full therapy, basic support, and standard depression care over a period of up to one year.
For: DepressionDenmark